The record starts accreting with the next priced report.
2-quarter memory
Positioning
3 expiries · as of the Sep 19 close
Contracts already committed, not just traded today. Puts against calls, sized by expiry.
176
▼ 1%
Oct 16
27d
first
1
1
0%
Nov 20
62d
▲ 2%
1,079
51
▲ 2%
Feb 19
153d
▲ 2%
3,317
putscalls
Linked exposure
placeholder
No linked names measured for this ticker yet.
Revenue flow
Q4 FY2015 derived from the annual figures · change vs Q3 FY2015
SURG kept 7.35% of Q4 FY2015 revenue as profit. Revenue +7.40% on Q3 FY2015, +15.55% on Q4 FY2014.
Revenue
$21M▲ +7.40% q/q
Gross profit
$11M▲ +11.41% q/q
54.10% margin
Cost of revenue
$10M▲ +3.03% q/q
Operating income
$2M▲ +11.14% q/q
9.45% margin
Operating expenses
$9M▲ +11.47% q/q
Marketing $4M
SG&A $4M
R&D $1M
Other operating $117,000
Pre-tax income
$2M▲ +12.36% q/q
Net income
$2M▲ +24.41% q/q
7.35% margin
Tax
$416,000▼ −17.13% q/q
Other expense
$22,000
Revenue$21M
Gross profit$11M54.10%
Operating income$2M9.45%
Pre-tax income$2M
Net income$2M7.35%
Cost of revenue
$10M · 45.90%
Operating expenses
$9M · 44.65%
Tax
$416,000 · 2.00%
Other expense leaves
$22,000 · 0.11%
SURG files a 10-K for this quarter rather than a 10-Q, so these lines are the full year less the three quarters before it, not figures filed for the quarter ended Jul 31 '15. Ribbon thickness is the dollar amount.
Event sensitivity
release-day history · not a forecast
NFPjobs report2.3×up 4 of 9±9.8% vs ±4.2% · 9
PPIproducer prices1.5×up 3 of 9±6.5% vs ±4.2% · 9
CPROFcorporate profits1.1×up 4 of 11±4.7% vs ±4.2% · 11
CPIconsumer prices1.0×up 4 of 9±4.3% vs ±4.2% · 9
GDPgross domestic product0.9×up 6 of 18±4.0% vs ±4.2% · 18
PCEpersonal income & outlays0.9×up 8 of 18±4.0% vs ±4.2% · 18
FOMCrate decision0.6×up 12 of 24±2.7% vs ±4.2% · 24
Past release days against SURG’s ordinary ±4.2% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.